The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Prothrombin and Factor V Mutations in Women with a History of Thrombosis during Pregnancy and the Puerperium
Open accessAbstract
BACKGROUND: Venous thromboembolism is a leading cause of morbidity and mortality during pregnancy and the puerperium. However, the role of mutations in the prothrombin and factor V genes and other thrombophilic abnormalities as risk factors for thromboembolism in women during pregnancy and the pueperium is not known. METHODS: In a study of 119 women with a history of venous thromboembolism during pregnancy and the puerperium and 233 age-matched normal women, we measured the activity of antithrombin, protein C, protein S, and lupus anticoagulant. We also performed genetic analyses to detect the G1691A mutation in the factor V gene (factor V Leiden), the G20210A mutation in the prothrombin gene, and the C677T mutation in the methylenetetrahydrofolate reductase gene. Blood samples were obtained at least three months post partum or after the cessation of lactation. RESULTS: Among the women with a history of venous thromboembolism, the prevalence of factor V Leiden was 43.7 percent, as compared with 7.7 percent among the normal women (relative risk of venous thromboembolism, 9.3; 95 percent confidence interval, 5.1 to 16.9); that of the G20210A prothrombin-gene mutation, 16.9 percent as compared with 1.3 percent (relative risk, 15.2; 95 percent confidence interval, 4.2 to 52.6); and that of both factor V Leiden and the G20210A prothrombin-gene mutation 9.3 percent as compared with 0 (estimated odds ratio, 107). Assuming an overall risk of 1 in 1500 pregnancies, the risk of thrombosis among carriers of factor V Leiden was 0.2 percent, among carriers of the G20210A prothrombin-gene mutation, 0.5 percent, and among carriers of both defects, 4.6 percent, as calculated in a multivariate analysis. CONCLUSIONS: The G20210A prothrombin-gene mutation and factor V Leiden individually are associated with an increased risk of venous thromboembolism during pregnancy and the puerperium, and the risk among women with both mutations is disproportionately higher than that among women with only one mutation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., Boers, G. J. H., den Heijer, M., Kluijtmans, L. A. J., van den Heuve, L. P., et al. (1995) · Nature Genetics · doi:10.1038/ng0595-111 · Cited by 5,653
Mutation in blood coagulation factor V associated with resistance to activated protein C
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A., & Reitsma, P. H. (1994) · Nature · doi:10.1038/369064a0 · Cited by 3,783
Poort, Sr., Rosendaal, F., Reitsma, P., & Bertina, R. (1996) · Blood · doi:10.1182/blood.v88.10.3698.bloodjournal88103698 · Cited by 3,079
Ridker, P. M., Hennekens, C. H., Lindpaintner, K., Stampfer, M. J., Eisenberg, P. R., & Miletich, J. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321403 · Cited by 1,035
Martinelli, I., Sacchi, E., Landi, G., Taioli, E., Duca, F., & Mannucci, P. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806183382502 · Cited by 648
Hillarp, A., Zӧller, B., Svensson, P. J., & Dahlbäck, B. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657674 · Cited by 243
Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism.
Eichinger, S., Stümpflen, A., Hirschl, M., Bialonczyk, C., Herkner, K. R., STAIN, M., Schneider, B., Pabinger, I., Lechner, K., & Kyrle, P. A. (1998) · PubMed · Cited by 220
Kluijtmans, L. A. J., den Heijer, M., Reitsma, P. H., Heil, S. G., Rosendaal, F. R., & Blom, H. J. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614974 · Cited by 151
Frezzato, M., Tosetto, A., & Rodeghiero, F. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008713 · Cited by 151
Margaglione, M., D’Andrea, G., d’Addedda, M., Giuliani, N., Cappucci, G., Iannaccone, L., Vecchione, G., Grandone, E., Brancaccio, V., & Minno, G. D. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615091 · Cited by 135
Cited by
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Thrombophilia in pregnancy: a systematic review
Robertson, L., Wu, O., Langhorne, P., Twaddle, S., Clark, P., Lowe, G. D. O., Walker, I. D., Greaves, M., Brenkel, I., Regan, L., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05847.x · Cited by 849
Genetic Susceptibility to Venous Thrombosis
Seligsohn, U., & Lubetsky, A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104193441607 · Cited by 822
Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Pabinger, I., Sofaer, S., & Hirsh, J. (2008) · Chest · doi:10.1378/chest.08-0761 · Cited by 793
POMP, E. R., LENSELINK, A. M., ROSENDAAL, F. R., & DOGGEN, C. J. M. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02921.x · Cited by 724
Metadata
- Authors
- Gerhardt, A., Scharf, R. E., Beckmann, M. W., Struve, S., Bender, H. G., Pillny, M., Sandmann, W., & Zotz, R. B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2000-02-10
- Volume
- 342
- Issue
- 6
- Pages
- 374-380
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2339659421
- Cited by
- 491
- References
- 13
- FWCI
- 21.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prothrombin and Factor V Mutations in Women with a History of Thrombosis during Pregnancy and the Puerperium. https://app.cochat.ai/papers/10.1056/nejm200002103420602
- The paper
- Gerhardt, A., Scharf, R. E., Beckmann, M. W., Struve, S., Bender, H. G., Pillny, M., Sandmann, W., & Zotz, R. B. (2000). Prothrombin and Factor V Mutations in Women with a History of Thrombosis during Pregnancy and the Puerperium. New England Journal of Medicine. https://doi.org/10.1056/nejm200002103420602
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.